Syneron Medical Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Irvine CA United States (2000)
Status: Acquired by Apax Partners (2017)

Organization Overview

First Clinical Trial
2018
NCT03257670
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Syneron Candela